We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HLI:NYSEHoulihan Lokey, Inc. Analysis

Data as of 2026-08-18 - not real-time

$127.01

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Houlihan Lokey, Inc. is bearish at $127.01, with short-term averages lagging the long-term ones. The last 30 days have lost 8.7%. RSI sits at 44.1, which reads as neutral, and MACD momentum is bearish. Price has been bracketed by support at $112.83 and resistance at $147.01.
On valuation the read is fair — earnings multiple of 21.3 versus a 16.9 sector average, above the peer group. Consensus targets land 20.9% above where the shares trade now. Revenue is contracting at 15.5% on a 16.1% profit margin. The 2.24% dividend yield looks covered by current payout levels.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 46.7%, a beta of 0.73 and a maximum drawdown of 41.0%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Timeframes disagree: the short-term read is sell while the long-term read is hold, conviction 1 out of 10.

Top Market Events

Shares of investment banking firm Houlihan Lokey NYSE:HLI fell 8.Investment banking firm Houlihan Lokey NYSE:HLI in Q2 CY2026, with sales falling 15.Ariel Investments, an investment management company, released its “Appreciation Fund” Q2 2026 investor letter.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 156.97
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 21.3 versus sector average of 16.9
  • Trading below the 200-day average of 156.97

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 21.3 versus sector average of 16.9
  • Analyst targets imply +20.9% versus the current price
  • Profit margin of 16.1% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth-15.50%
Profit Margin16.08%
P/E Ratio21.3
ROE17.79%
ROA11.17%
Debt/Equity20.85
P/B Ratio3.9
Op. Cash Flow$500.1M
Industry P/E16.9

Technical Analysis

TrendBearish
RSI44.1
Support$112.83
Resistance$147.01
MA 20$131.05
MA 50$135.53
MA 200$156.97
MACDBearish
VolumeDecreasing
Fear & Greed Index93.14

Valuation

Fair Value$67.46
Target Price$153.50
Upside/Downside20.86%
GradeFair
TypeBlend
Dividend Yield2.24%

Risk Assessment

Beta0.73
Volatility46.66%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.